Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP985325.RAV-YxI-x5FtxC4Ua152NPN9Dhh8YE7WtRI77d494bMso130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP985325.RAV-YxI-x5FtxC4Ua152NPN9Dhh8YE7WtRI77d494bMso130_assertion type Assertion NP985325.RAV-YxI-x5FtxC4Ua152NPN9Dhh8YE7WtRI77d494bMso130_head.
- NP985325.RAV-YxI-x5FtxC4Ua152NPN9Dhh8YE7WtRI77d494bMso130_assertion description "[In Langerhans cells, niacin initiates GPR109A-mediated signaling pathways (Erk1/2 and Ca(2+)) responsible for the release of vasodilatory prostanoids, while the synthetic GPR109A agonist MK-0354 fails to elicit any signaling, providing a mechanistic basis for the latter compound's inability to cause flushing.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP985325.RAV-YxI-x5FtxC4Ua152NPN9Dhh8YE7WtRI77d494bMso130_provenance.
- NP985325.RAV-YxI-x5FtxC4Ua152NPN9Dhh8YE7WtRI77d494bMso130_assertion evidence source_evidence_literature NP985325.RAV-YxI-x5FtxC4Ua152NPN9Dhh8YE7WtRI77d494bMso130_provenance.
- NP985325.RAV-YxI-x5FtxC4Ua152NPN9Dhh8YE7WtRI77d494bMso130_assertion SIO_000772 23770183 NP985325.RAV-YxI-x5FtxC4Ua152NPN9Dhh8YE7WtRI77d494bMso130_provenance.
- NP985325.RAV-YxI-x5FtxC4Ua152NPN9Dhh8YE7WtRI77d494bMso130_assertion wasDerivedFrom befree-20150227 NP985325.RAV-YxI-x5FtxC4Ua152NPN9Dhh8YE7WtRI77d494bMso130_provenance.
- NP985325.RAV-YxI-x5FtxC4Ua152NPN9Dhh8YE7WtRI77d494bMso130_assertion wasGeneratedBy ECO_0000203 NP985325.RAV-YxI-x5FtxC4Ua152NPN9Dhh8YE7WtRI77d494bMso130_provenance.